Cargando…

Oral Semaglutide

Detalles Bibliográficos
Autores principales:	Bui, Vinh, Neumiller, Joshua J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2018
Materias:	Departments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187952/ https://www.ncbi.nlm.nih.gov/pubmed/30364001 http://dx.doi.org/10.2337/cd18-0034

Ejemplares similares

Diabetes Spectrum: Past, Present, and Future
por: Neumiller, Joshua J.
Publicado: (2018)

Prandial Insulin Dosing: How Long Does It Take to Go 80 Miles?
por: Mystkowski, Paul, et al.
Publicado: (2016)

Medtronic MiniMed 670G Hybrid Closed-Loop System
por: Knebel, Tory, et al.
Publicado: (2019)

Management of Hyperglycemia in Diabetic Kidney Disease
por: Neumiller, Joshua J., et al.
Publicado: (2015)

Oral Semaglutide: Dosage in Special Situations
por: Kalra, Sanjay, et al.
Publicado: (2022)

Efficacy of Semaglutide in a Subcutaneous and an Oral Formulation
por: Meier, Juris J.
Publicado: (2021)

A Review on the Efficacy and Safety of Oral Semaglutide
por: Niman, Stephanie, et al.
Publicado: (2021)

Advances in GLP-1 treatment: focus on oral semaglutide
por: Eliaschewitz, Freddy G., et al.
Publicado: (2021)

Clinical Perspectives on the Use of Subcutaneous and Oral Formulations of Semaglutide
por: Gallwitz, Baptist, et al.
Publicado: (2021)

Safety of Semaglutide
por: Smits, Mark M., et al.
Publicado: (2021)

Oral Manifestations of Diabetes
por: Indurkar, Maya S., et al.
Publicado: (2016)

Pharmacokinetics, Safety, and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment
por: Bækdal, Tine A., et al.
Publicado: (2018)

Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment
por: Granhall, Charlotte, et al.
Publicado: (2018)

Corrigendum: Safety of Semaglutide
por: Smits, Mark M., et al.
Publicado: (2021)

Pandemic Considerations on Essential Oral Health Care
por: Benzian, H., et al.
Publicado: (2020)

Consensus Statement on Future Directions for the Behavioral and Social Sciences in Oral Health
por: McNeil, D.W., et al.
Publicado: (2022)

Normative Approaches for Oral Health: Standards, Specifications, and Guidelines
por: Schmalz, G., et al.
Publicado: (2021)

Rethinking Oral Health in Aging: Ecosocial Theory and Intersectionality
por: Slack-Smith, L., et al.
Publicado: (2023)

Management of type 2 diabetes with oral semaglutide: Practical guidance for pharmacists
por: Kane, Michael P, et al.
Publicado: (2020)

First-in-Class Oral Semaglutide: Overcoming Barriers of Incretinisation in the Indian Context
por: Rajput, Rajesh, et al.
Publicado: (2022)

Oral Semaglutide: Balancing Promising Therapeutics with Adverse Effects and Access Barriers
por: Gunning, Karen
Publicado: (2020)

Data-Driven Dental, Oral, and Craniofacial Analytics: Here to Stay
por: Schwendicke, F., et al.
Publicado: (2022)

Dental Medicine and Engineering Unite to Transform Oral Health Innovations
por: Koo, H., et al.
Publicado: (2023)

The long-term cost-effectiveness of oral semaglutide versus empagliflozin and dulaglutide in Portugal
por: Malkin, Samuel J. P., et al.
Publicado: (2022)

Oral Health Equity Must Address Oppression: On the BSSOH Consensus Statement
por: Raskin, S.E., et al.
Publicado: (2022)

Areca Nut and Oral Cancer: Evidence from Studies Conducted in Humans
por: Warnakulasuriya, S., et al.
Publicado: (2022)

Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS)
por: Janić, Miodrag, et al.
Publicado: (2022)

Research for Prevention of Oral/Dental Diseases: How Far Have We Come?
por: Schwendicke, F., et al.
Publicado: (2019)

The Discovery and Development of Liraglutide and Semaglutide
por: Knudsen, Lotte Bjerre, et al.
Publicado: (2019)

Semaglutide for type 2 diabetes
Publicado: (2020)

Semaglutide-associated bullous pemphigoid
por: Burruss, Clayton P., et al.
Publicado: (2021)

Semaglutide-eye-catching results
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2023)

Emerging Anesthesia Risks with Semaglutide
por: Fezza, Reed, et al.
Publicado: (2023)

Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine
por: Meng, L., et al.
Publicado: (2020)

Effect of Oral Semaglutide on the Pharmacokinetics of Lisinopril, Warfarin, Digoxin, and Metformin in Healthy Subjects
por: Bækdal, Tine A., et al.
Publicado: (2019)

Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date
por: Pearson, Sam, et al.
Publicado: (2019)

Insights into the early use of oral semaglutide in routine clinical practice: The IGNITE study
por: Aroda, Vanita R., et al.
Publicado: (2021)

Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials
por: Overgaard, Rune V., et al.
Publicado: (2021)

A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes
por: Andersen, Andreas, et al.
Publicado: (2021)

Relationship Between Oral Semaglutide Tablet Erosion and Pharmacokinetics: A Pharmacoscintigraphic Study
por: Bækdal, Tine A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gp9lsk4ine6fpuln6hn4edoeqd